advertisement
Huang L 28
Showing records 1 to 25 | Display all abstracts from Huang L105856 Magnolol limits NFκB-dependent inflammation by targeting PPARγ relieving retinal ischemia/reperfusion injury
Wang N
International immunopharmacology 2022; 112: 109242
106448 Associations Among Multimorbid Conditions in Hospitalized Middle-aged and Older Adults in China: Statistical Analysis of Medical Records
Zhang Y
JMIR public health and surveillance 2022; 8: e38182
105975 AZD6738 Inhibits fibrotic response of conjunctival fibroblasts by regulating checkpoint kinase 1/ and / pathways
Huang L
Frontiers in pharmacology 2022; 13: 990401
106287 AZD6738 decreases intraocular pressure and inhibits fibrotic response in trabecular meshwork through CHK1/P53 pathway
Huang L; Wei Z
Biochemical Pharmacology 2022; 206: 115340
106448 Associations Among Multimorbid Conditions in Hospitalized Middle-aged and Older Adults in China: Statistical Analysis of Medical Records
Chen C
JMIR public health and surveillance 2022; 8: e38182
105856 Magnolol limits NFκB-dependent inflammation by targeting PPARγ relieving retinal ischemia/reperfusion injury
Yang Y
International immunopharmacology 2022; 112: 109242
105975 AZD6738 Inhibits fibrotic response of conjunctival fibroblasts by regulating checkpoint kinase 1/ and / pathways
Ye Q
Frontiers in pharmacology 2022; 13: 990401
106448 Associations Among Multimorbid Conditions in Hospitalized Middle-aged and Older Adults in China: Statistical Analysis of Medical Records
Huang L
JMIR public health and surveillance 2022; 8: e38182
105975 AZD6738 Inhibits fibrotic response of conjunctival fibroblasts by regulating checkpoint kinase 1/ and / pathways
Lan C
Frontiers in pharmacology 2022; 13: 990401
105856 Magnolol limits NFκB-dependent inflammation by targeting PPARγ relieving retinal ischemia/reperfusion injury
Liu Y
International immunopharmacology 2022; 112: 109242
106287 AZD6738 decreases intraocular pressure and inhibits fibrotic response in trabecular meshwork through CHK1/P53 pathway
Wang X
Biochemical Pharmacology 2022; 206: 115340
105856 Magnolol limits NFκB-dependent inflammation by targeting PPARγ relieving retinal ischemia/reperfusion injury
Huang L
International immunopharmacology 2022; 112: 109242
105975 AZD6738 Inhibits fibrotic response of conjunctival fibroblasts by regulating checkpoint kinase 1/ and / pathways
Wang X
Frontiers in pharmacology 2022; 13: 990401
106287 AZD6738 decreases intraocular pressure and inhibits fibrotic response in trabecular meshwork through CHK1/P53 pathway
Lan C
Biochemical Pharmacology 2022; 206: 115340
106448 Associations Among Multimorbid Conditions in Hospitalized Middle-aged and Older Adults in China: Statistical Analysis of Medical Records
Liu G; Lian T
JMIR public health and surveillance 2022; 8: e38182
105856 Magnolol limits NFκB-dependent inflammation by targeting PPARγ relieving retinal ischemia/reperfusion injury
Gu M
International immunopharmacology 2022; 112: 109242
105975 AZD6738 Inhibits fibrotic response of conjunctival fibroblasts by regulating checkpoint kinase 1/ and / pathways
Zhu Y
Frontiers in pharmacology 2022; 13: 990401
106287 AZD6738 decreases intraocular pressure and inhibits fibrotic response in trabecular meshwork through CHK1/P53 pathway
Zhu Y
Biochemical Pharmacology 2022; 206: 115340
105856 Magnolol limits NFκB-dependent inflammation by targeting PPARγ relieving retinal ischemia/reperfusion injury
Wu Y
International immunopharmacology 2022; 112: 109242
106448 Associations Among Multimorbid Conditions in Hospitalized Middle-aged and Older Adults in China: Statistical Analysis of Medical Records
Yin M
JMIR public health and surveillance 2022; 8: e38182
106287 AZD6738 decreases intraocular pressure and inhibits fibrotic response in trabecular meshwork through CHK1/P53 pathway
Ye Q
Biochemical Pharmacology 2022; 206: 115340
106448 Associations Among Multimorbid Conditions in Hospitalized Middle-aged and Older Adults in China: Statistical Analysis of Medical Records
Zhao Z
JMIR public health and surveillance 2022; 8: e38182
105856 Magnolol limits NFκB-dependent inflammation by targeting PPARγ relieving retinal ischemia/reperfusion injury
Xu L
International immunopharmacology 2022; 112: 109242
106448 Associations Among Multimorbid Conditions in Hospitalized Middle-aged and Older Adults in China: Statistical Analysis of Medical Records
Xu J
JMIR public health and surveillance 2022; 8: e38182
105856 Magnolol limits NFκB-dependent inflammation by targeting PPARγ relieving retinal ischemia/reperfusion injury
Sun H
International immunopharmacology 2022; 112: 109242
